[The role of immunotherapy in the treatment of patients with hematologic neoplasms].
Rukavitsyn
O A
OA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D003713:Dendritic Cells; D019337:Hematologic Neoplasms / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D016233:Immunotherapy, Active / Q000379:methods; D016219:Immunotherapy, Adoptive; D007378:Interleukins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D007378:Interleukins